{"hands_on_practices": [{"introduction": "The Cancer Stem Cell (CSC) model has evolved from a rigid hierarchy to a more dynamic concept involving phenotypic plasticity. This exercise models the interconversion between CSC and non-stem cancer cell (NSCC) states as a dynamic equilibrium. By calculating the steady-state CSC fraction, you can quantitatively explore how signals from the tumor microenvironment, such as hypoxia, can shift this balance and enrich the tumor with treatment-resistant stem-like cells [@problem_id:4462511].", "problem": "A well-mixed tumor cell population consists of two phenotypic states: Cancer Stem Cells (CSC) and non-stem cancer cells (NSCC). Let the CSC fraction be denoted by $f(t)$, so that the NSCC fraction is $1 - f(t)$. On the time scale of interest, assume that net proliferation and death rates are equal across the two phenotypes such that changes in $f(t)$ are governed only by phenotypic interconversion. Define $k_{SN}$ (units: day$^{-1}$) as the per-cell hazard rate for CSC to convert to NSCC, and $k_{NS}$ (units: day$^{-1}$) as the per-cell hazard rate for NSCC to convert to CSC. Treat the system as a continuous-time, two-state Markov process with constant rates over the time interval of interest and assume it reaches a steady state.\n\nStarting from conservation of probability and flow balance between the two states, derive the ordinary differential equation governing $f(t)$ and solve for the steady-state fraction $f^{*}$ in terms of $k_{SN}$ and $k_{NS}$.\n\nIn a baseline condition, measurements yield $k_{SN}^{(0)} = 0.08$ day$^{-1}$ and $k_{NS}^{(0)} = 0.02$ day$^{-1}$. In a hypoxic tumor microenvironment (TME), the dedifferentiation rate increases by a fold-change $\\alpha = 3.5$ while the differentiation rate decreases by a multiplicative factor $\\beta = 0.75$. That is, under hypoxia, $k_{NS} = \\alpha \\, k_{NS}^{(0)}$ and $k_{SN} = \\beta \\, k_{SN}^{(0)}$. Using your steady-state expression, compute the hypoxia-steady-state CSC fraction $f^{*}$.\n\nExpress your final answer as a decimal fraction with no units, rounded to four significant figures. Do not use a percentage sign. Briefly, in your derivation, explain how the TME-induced modulation of $k_{NS}$ and $k_{SN}$ alters $f^{*}$ mechanistically.", "solution": "The problem is valid. It is scientifically grounded, well-posed, and objective, allowing for a formal mathematical solution.\n\nWe begin by establishing the governing ordinary differential equation (ODE) for the fraction of Cancer Stem Cells (CSCs), denoted by $f(t)$. The system consists of two states: CSCs and non-stem cancer cells (NSCCs). The total cell population is $N(t)$, with $N_{CSC}(t)$ being the number of CSCs and $N_{NSCC}(t)$ being the number of NSCCs, such that $N(t) = N_{CSC}(t) + N_{NSCC}(t)$. The fractions are $f(t) = \\frac{N_{CSC}(t)}{N(t)}$ and $1 - f(t) = \\frac{N_{NSCC}(t)}{N(t)}$.\n\nThe problem states that changes in the fraction $f(t)$ are governed solely by phenotypic interconversion. Let $k_{SN}$ be the rate constant for CSC differentiation into NSCC, and $k_{NS}$ be the rate constant for NSCC dedifferentiation into CSC. The rate of change in the number of CSCs, accounting for conversions and a general net proliferation rate $g$ (assumed to be identical for both phenotypes), is given by:\n$$\n\\frac{d N_{CSC}}{dt} = g N_{CSC}(t) + k_{NS} N_{NSCC}(t) - k_{SN} N_{CSC}(t)\n$$\nThe total population grows according to $\\frac{dN}{dt} = gN(t)$.\n\nTo find the ODE for the fraction $f(t)$, we use the quotient rule for differentiation:\n$$\n\\frac{df}{dt} = \\frac{d}{dt} \\left( \\frac{N_{CSC}}{N} \\right) = \\frac{1}{N} \\frac{dN_{CSC}}{dt} - \\frac{N_{CSC}}{N^2} \\frac{dN}{dt}\n$$\nSubstituting the expressions for $\\frac{dN_{CSC}}{dt}$ and $\\frac{dN}{dt}$:\n$$\n\\frac{df}{dt} = \\frac{1}{N} [g N_{CSC} + k_{NS} N_{NSCC} - k_{SN} N_{CSC}] - \\frac{N_{CSC}}{N^2} [g N]\n$$\nSimplifying the expression:\n$$\n\\frac{df}{dt} = g \\frac{N_{CSC}}{N} + k_{NS} \\frac{N_{NSCC}}{N} - k_{SN} \\frac{N_{CSC}}{N} - g \\frac{N_{CSC}}{N}\n$$\nThe terms involving the net proliferation rate $g$ cancel out, confirming that under the assumption of equal proliferation rates, the dynamics of the fraction $f(t)$ depend only on the interconversion rates:\n$$\n\\frac{df}{dt} = k_{NS} \\frac{N_{NSCC}(t)}{N(t)} - k_{SN} \\frac{N_{CSC}(t)}{N(t)}\n$$\nSubstituting the fractional representations $f(t)$ and $1-f(t)$:\n$$\n\\frac{df}{dt} = k_{NS} (1 - f(t)) - k_{SN} f(t)\n$$\nThis is the ordinary differential equation governing $f(t)$.\n\nTo find the steady-state fraction, $f^*$, we set the time derivative to zero, $\\frac{df}{dt} = 0$:\n$$\n0 = k_{NS} (1 - f^*) - k_{SN} f^*\n$$\nThis equation describes the flow balance at equilibrium, where the rate of cells becoming CSCs equals the rate of cells ceasing to be CSCs. Solving for $f^*$:\n$$\nk_{NS} (1 - f^*) = k_{SN} f^*\n$$\n$$\nk_{NS} - k_{NS} f^* = k_{SN} f^*\n$$\n$$\nk_{NS} = (k_{SN} + k_{NS}) f^*\n$$\n$$\nf^* = \\frac{k_{NS}}{k_{SN} + k_{NS}}\n$$\nThis expression gives the steady-state CSC fraction in terms of the two interconversion rates.\n\nMechanistically, the steady-state fraction $f^*$ is determined by the balance of differentiation ($k_{SN}$) and dedifferentiation ($k_{NS}$) rates. The expression can be rewritten as $f^* = \\frac{1}{1 + k_{SN}/k_{NS}}$. This form highlights that the equilibrium depends on the ratio of the two rates. The hypoxic tumor microenvironment (TME) modulates these rates. It increases the dedifferentiation rate $k_{NS}$ by a factor $\\alpha > 1$ and decreases the differentiation rate $k_{SN}$ by a factor $\\beta < 1$. Both of these changes cause the ratio $k_{SN}/k_{NS}$ to decrease. A smaller $k_{SN}/k_{NS}$ ratio leads to a larger value for $f^*$. Thus, the hypoxic TME shifts the dynamic equilibrium towards a higher proportion of CSCs by simultaneously promoting their formation and inhibiting their loss.\n\nWe are given the baseline rates and the modulation factors:\n- Baseline differentiation rate: $k_{SN}^{(0)} = 0.08$ day$^{-1}$\n- Baseline dedifferentiation rate: $k_{NS}^{(0)} = 0.02$ day$^{-1}$\n- Dedifferentiation fold-change under hypoxia: $\\alpha = 3.5$\n- Differentiation multiplicative factor under hypoxia: $\\beta = 0.75$\n\nThe rates under hypoxia are:\n$$\nk_{NS} = \\alpha \\, k_{NS}^{(0)} = 3.5 \\times 0.02 \\, \\text{day}^{-1} = 0.07 \\, \\text{day}^{-1}\n$$\n$$\nk_{SN} = \\beta \\, k_{SN}^{(0)} = 0.75 \\times 0.08 \\, \\text{day}^{-1} = 0.06 \\, \\text{day}^{-1}\n$$\nNow we compute the new steady-state CSC fraction $f^*$ using these hypoxic rates:\n$$\nf^* = \\frac{k_{NS}}{k_{SN} + k_{NS}} = \\frac{0.07}{0.06 + 0.07} = \\frac{0.07}{0.13}\n$$\nCalculating the numerical value:\n$$\nf^* \\approx 0.5384615...\n$$\nRounding to four significant figures, we get:\n$$\nf^* = 0.5385\n$$", "answer": "$$\\boxed{0.5385}$$", "id": "4462511"}, {"introduction": "The tumor microenvironment is spatially organized, with gradients of oxygen, nutrients, and signaling molecules creating distinct niches. This practice uses a classic reaction-diffusion model to determine the characteristic length scale of oxygen penetration into tumor tissue from a blood vessel. Calculating this 'oxygen diffusion length' provides a physical basis for understanding where hypoxic niches—key regulators of CSC fate—are likely to form and persist [@problem_id:4462590].", "problem": "A solid tumor region can be idealized as a one-dimensional slab in which dissolved oxygen diffuses from a well-perfused microvessel at position $x=0$ into tissue at $x>0$. Oxygen is consumed by cells with first-order kinetics characterized by a rate constant $k$ (units $\\text{s}^{-1}$), and diffuses with coefficient $D$ (units $\\text{cm}^{2}\\,\\text{s}^{-1}$). Assume steady state and spatial uniformity of parameters, so that the dissolved oxygen concentration $c(x)$ satisfies the steady-state diffusion–consumption equation based on Fick’s law,\n$$D\\,\\frac{d^{2}c}{dx^{2}}-k\\,c=0,$$\nwith boundary conditions $c(0)=c_{0}$ and $c(x)\\to 0$ as $x\\to \\infty$. Define the characteristic oxygen diffusion length $L$ as the positive distance at which the concentration has decayed to $c_{0}\\exp(-1)$, that is, $c(L)=c_{0}\\exp(-1)$. Starting from the stated equation and boundary conditions, derive $L$ in terms of $D$ and $k$, then evaluate it for $D=2\\times 10^{-5}$ $\\text{cm}^{2}\\,\\text{s}^{-1}$ and $k=0.1$ $\\text{s}^{-1}$. Express your final numerical answer in micrometers and round your answer to three significant figures. Briefly interpret what this length scale implies for the likely localization of Cancer Stem Cells (CSC) relative to microvessels and hypoxic niches, based on oxygen availability in the tumor microenvironment.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded, well-posed, and objective. It presents a standard reaction-diffusion model used in biophysics with sufficient information to derive a unique solution.\n\nThe problem describes the steady-state concentration of dissolved oxygen, $c(x)$, in a one-dimensional tissue slab. The governing ordinary differential equation (ODE) is given as:\n$$D\\,\\frac{d^{2}c}{dx^{2}}-k\\,c=0$$\nwhere $D$ is the diffusion coefficient, $k$ is the first-order consumption rate constant, and $x$ is the distance from the microvessel. The equation can be rewritten in a standard form:\n$$\\frac{d^{2}c}{dx^{2}} - \\frac{k}{D}c = 0$$\nThis is a second-order, linear, homogeneous differential equation with constant coefficients. The characteristic equation is obtained by substituting $c(x) = \\exp(rx)$:\n$$r^{2} - \\frac{k}{D} = 0$$\nThe roots of the characteristic equation are:\n$$r = \\pm\\sqrt{\\frac{k}{D}}$$\nThe general solution to the ODE is a linear combination of the exponential functions corresponding to these roots:\n$$c(x) = A\\exp\\left(\\sqrt{\\frac{k}{D}}x\\right) + B\\exp\\left(-\\sqrt{\\frac{k}{D}}x\\right)$$\nwhere $A$ and $B$ are constants to be determined by the boundary conditions.\n\nThe boundary conditions are:\n1.  $c(0) = c_{0}$: At the microvessel ($x=0$), the oxygen concentration is a constant $c_{0}$.\n2.  $c(x) \\to 0$ as $x \\to \\infty$: Far from the microvessel, the oxygen is fully consumed, and its concentration approaches zero.\n\nApplying the second boundary condition, as $x \\to \\infty$, the term $A\\exp\\left(\\sqrt{\\frac{k}{D}}x\\right)$ will grow infinitely large if $A \\neq 0$. To satisfy the condition that $c(x) \\to 0$, the constant $A$ must be zero. This simplifies the solution to:\n$$c(x) = B\\exp\\left(-\\sqrt{\\frac{k}{D}}x\\right)$$\nNow, applying the first boundary condition, $c(0) = c_{0}$:\n$$c(0) = B\\exp(0) = B \\cdot 1 = B$$\nThus, $B = c_{0}$. The specific solution for the oxygen concentration profile is:\n$$c(x) = c_{0}\\exp\\left(-\\sqrt{\\frac{k}{D}}x\\right)$$\nThe problem defines the characteristic oxygen diffusion length, $L$, as the positive distance at which the concentration has decayed to $c(L) = c_{0}\\exp(-1)$. We can find $L$ by setting our specific solution equal to this definition at $x=L$:\n$$c_{0}\\exp\\left(-\\sqrt{\\frac{k}{D}}L\\right) = c_{0}\\exp(-1)$$\nDividing both sides by $c_{0}$ and equating the exponents gives:\n$$-\\sqrt{\\frac{k}{D}}L = -1$$\nSolving for $L$, we obtain the analytical expression in terms of $D$ and $k$:\n$$L = \\frac{1}{\\sqrt{\\frac{k}{D}}} = \\sqrt{\\frac{D}{k}}$$\nNext, we evaluate $L$ using the given numerical values: $D = 2 \\times 10^{-5}$ $\\text{cm}^{2}\\,\\text{s}^{-1}$ and $k = 0.1$ $\\text{s}^{-1}$.\n$$L = \\sqrt{\\frac{2 \\times 10^{-5}\\,\\text{cm}^{2}\\,\\text{s}^{-1}}{0.1\\,\\text{s}^{-1}}} = \\sqrt{2 \\times 10^{-4}\\,\\text{cm}^{2}}$$\n$$L = \\sqrt{2} \\times \\sqrt{10^{-4}}\\,\\text{cm} = \\sqrt{2} \\times 10^{-2}\\,\\text{cm}$$\nThe problem requires the answer in micrometers ($\\mu\\text{m}$). We use the conversion factor $1\\,\\text{cm} = 10^{4}\\,\\mu\\text{m}$:\n$$L = (\\sqrt{2} \\times 10^{-2})\\,\\text{cm} \\times \\frac{10^{4}\\,\\mu\\text{m}}{1\\,\\text{cm}} = \\sqrt{2} \\times 10^{2}\\,\\mu\\text{m}$$\nCalculating the numerical value:\n$$L \\approx 1.41421356... \\times 100\\,\\mu\\text{m} \\approx 141.421356...\\,\\mu\\text{m}$$\nRounding to three significant figures, we get:\n$$L \\approx 141\\,\\mu\\text{m}$$\nBrief interpretation: The characteristic length $L \\approx 141\\,\\mu\\text{m}$ represents the spatial scale over which oxygen supplied by a microvessel is substantially consumed by the tumor tissue. Regions at distances significantly greater than $L$ from a blood vessel will have very low oxygen levels, a condition known as hypoxia. It is well-established that such hypoxic niches within the tumor microenvironment can promote the survival and maintenance of Cancer Stem Cells (CSCs). These cells are often quiescent, resistant to radiation and chemotherapy, and are capable of regenerating the tumor. Therefore, this calculated length scale implies that CSCs are likely to be enriched in regions located approximately $141\\,\\mu\\text{m}$ or more from the nearest microvessel, while the more proliferative, non-stem cancer cells would dominate the better-oxygenated regions closer to the vasculature. This spatial zonation is a critical factor in tumor biology and therapy resistance.", "answer": "$$\\boxed{141}$$", "id": "4462590"}, {"introduction": "A critical feature of CSCs is their ability to enter a dormant or quiescent state, rendering them insensitive to chemotherapies that target rapidly dividing cells. This exercise applies principles of survival analysis to model the dynamics of a dormant CSC population under changing microenvironmental conditions. By calculating the fraction of CSCs that remain dormant over time, you can appreciate how the TME contributes to the reservoir of cells responsible for tumor relapse [@problem_id:4462558].", "problem": "A tumor contains a subpopulation of dormant cancer stem cells (CSCs) embedded in a heterogeneous tumor microenvironment (TME). An investigator models exit from dormancy for an individual CSC as a memoryless time-to-event process with a constant hazard rate within each microenvironmental phase. During a period of TME hypoxia that stabilizes dormancy, the per-cell hazard of exiting dormancy is reduced; during reoxygenation with restored nutrient availability, the per-cell hazard increases. Assume no replenishment of the dormant pool from proliferating cells and that chemotherapy eliminates only cells that have exited dormancy.\n\nFrom first principles about memoryless processes and the definition of a hazard rate, derive a survival function for the probability that a CSC remains dormant up to time $t$ when the hazard is piecewise constant. Then compute the fraction of dormant CSCs remaining after a total of $90$ days in the following schedule:\n- Hypoxic phase: first $40$ days with hazard $\\lambda_{h} = 3.0 \\times 10^{-3} \\ \\text{day}^{-1}$.\n- Reoxygenated phase: next $50$ days with hazard $\\lambda_{n} = 1.2 \\times 10^{-2} \\ \\text{day}^{-1}$.\n\nState your final numeric answer as a unitless decimal between $0$ and $1$, rounded to four significant figures. Briefly explain in your reasoning what this implies for chemoresistance if chemotherapy targets only proliferating (non-dormant) cells.", "solution": "The problem asks for the derivation of a survival function for a process with a piecewise constant hazard rate and its application to calculate the fraction of dormant cancer stem cells (CSCs) remaining after a specified time course. The process of a CSC exiting dormancy is modeled as a memoryless time-to-event process.\n\nFirst, we validate the problem statement.\nThe givens are:\n- The process is memoryless with a piecewise constant hazard rate, $\\lambda(t)$.\n- Phase 1 (Hypoxic): Duration $t_1 = 40 \\ \\text{days}$, hazard rate $\\lambda_{h} = 3.0 \\times 10^{-3} \\ \\text{day}^{-1}$.\n- Phase 2 (Reoxygenated): Duration $t_2 = 50 \\ \\text{days}$, hazard rate $\\lambda_{n} = 1.2 \\times 10^{-2} \\ \\text{day}^{-1}$.\n- Total time $T_{total} = t_1 + t_2 = 90 \\ \\text{days}$.\n- Assumptions: No replenishment of the dormant pool; chemotherapy acts only on non-dormant cells.\n- The final answer is to be a decimal rounded to four significant figures.\n\nThe problem is scientifically grounded, modeling a biological process with standard mathematical tools from survival analysis. The concepts (CSC, TME, hypoxia, dormancy) are central to cancer biology. The problem is well-posed, with all necessary data provided to compute a unique solution. The language is objective and precise. The problem is deemed valid.\n\nWe proceed with the solution, starting from first principles.\nLet $T$ be a non-negative random variable representing the time until a CSC exits dormancy. The survival function, $S(t)$, is the probability that the cell remains dormant beyond time $t$:\n$$S(t) = P(T \\ge t)$$\nThe probability density function, $f(t)$, for the event time is given by the negative derivative of the survival function:\n$$f(t) = -\\frac{dS(t)}{dt}$$\nThe hazard rate, $\\lambda(t)$, is the instantaneous rate of exiting dormancy at time $t$, given that the cell has remained dormant up to time $t$. It is defined as:\n$$\\lambda(t) = \\lim_{\\Delta t \\to 0} \\frac{P(t \\le T < t + \\Delta t \\mid T \\ge t)}{\\Delta t}$$\nUsing the definition of conditional probability, $P(A|B) = P(A \\cap B) / P(B)$, this becomes:\n$$\\lambda(t) = \\lim_{\\Delta t \\to 0} \\frac{P(t \\le T < t + \\Delta t)}{\\Delta t \\cdot P(T \\ge t)} = \\frac{1}{S(t)} \\lim_{\\Delta t \\to 0} \\frac{P(t_0 \\le T < t_0 + \\Delta t)}{\\Delta t} \\Big|_{t_0=t}$$\nThe limit term is the definition of the probability density function, $f(t)$. Therefore, the hazard rate is related to the survival and density functions by:\n$$\\lambda(t) = \\frac{f(t)}{S(t)}$$\nSubstituting $f(t) = -dS(t)/dt$, we obtain a first-order ordinary differential equation for $S(t)$:\n$$\\lambda(t) = -\\frac{1}{S(t)} \\frac{dS(t)}{dt} = -\\frac{d}{dt} \\ln(S(t))$$\nTo find the survival function $S(t)$, we integrate the hazard rate from $0$ to $t$:\n$$\\int_0^t \\lambda(\\tau) d\\tau = -\\int_0^t \\frac{d}{d\\tau} \\ln(S(\\tau)) d\\tau = -[\\ln(S(\\tau))]_0^t = -(\\ln(S(t)) - \\ln(S(0)))$$\nAt time $t=0$, all cells are dormant, so the probability of survival to time $0$ is $S(0)=1$. This implies $\\ln(S(0)) = \\ln(1) = 0$. The equation simplifies to:\n$$-\\ln(S(t)) = \\int_0^t \\lambda(\\tau) d\\tau$$\nExponentiating both sides yields the general expression for the survival function in terms of the hazard rate:\n$$S(t) = \\exp\\left(-\\int_0^t \\lambda(\\tau) d\\tau\\right)$$\nThe integral in the exponent, $H(t) = \\int_0^t \\lambda(\\tau) d\\tau$, is known as the cumulative hazard function. The memoryless property of the process implies a constant hazard rate within any given phase, which is consistent with the problem statement.\n\nNow, we apply this derived function to the specific piecewise constant hazard rate given in the problem. The hazard rate is defined as:\n$$\n\\lambda(t) =\n\\begin{cases}\n\\lambda_h & \\text{for } 0 \\le t \\le 40 \\ \\text{days} \\\\\n\\lambda_n & \\text{for } 40 < t \\le 90 \\ \\text{days}\n\\end{cases}\n$$\nWe need to compute the fraction of dormant CSCs remaining at $t = 90 \\ \\text{days}$, which is given by $S(90)$. We must evaluate the cumulative hazard integral over the two distinct phases:\n$$S(90) = \\exp\\left(-\\int_0^{90} \\lambda(\\tau) d\\tau\\right) = \\exp\\left[-\\left(\\int_0^{40} \\lambda_h d\\tau + \\int_{40}^{90} \\lambda_n d\\tau\\right)\\right]$$\nWe calculate each integral separately. Since $\\lambda_h$ and $\\lambda_n$ are constants within their respective intervals:\n$$\\int_0^{40} \\lambda_h d\\tau = \\lambda_h \\int_0^{40} d\\tau = \\lambda_h (40 - 0) = 40\\lambda_h$$\n$$\\int_{40}^{90} \\lambda_n d\\tau = \\lambda_n \\int_{40}^{90} d\\tau = \\lambda_n (90 - 40) = 50\\lambda_n$$\nSubstituting the given numerical values for the hazard rates, $\\lambda_{h} = 3.0 \\times 10^{-3} \\ \\text{day}^{-1}$ and $\\lambda_{n} = 1.2 \\times 10^{-2} \\ \\text{day}^{-1}$:\nCumulative hazard from the hypoxic phase:\n$$H_h = 40 \\ \\text{days} \\times (3.0 \\times 10^{-3} \\ \\text{day}^{-1}) = 0.12$$\nCumulative hazard from the reoxygenated phase:\n$$H_n = 50 \\ \\text{days} \\times (1.2 \\times 10^{-2} \\ \\text{day}^{-1}) = 0.60$$\nThe total cumulative hazard at $t=90 \\ \\text{days}$ is the sum of the hazards from both phases:\n$$H(90) = H_h + H_n = 0.12 + 0.60 = 0.72$$\nThe survival probability, which represents the fraction of dormant CSCs remaining, is:\n$$S(90) = \\exp(-H(90)) = \\exp(-0.72)$$\nCalculating the numerical value:\n$$S(90) \\approx 0.486752256...$$\nRounding to four significant figures, as requested:\n$$S(90) \\approx 0.4868$$\nThis result implies that after the $90$-day period, approximately $48.68\\%$ of the initial CSC population remains in the dormant state.\n\nRegarding the implication for chemoresistance: The problem states that chemotherapy eliminates only cells that have exited dormancy (i.e., proliferating cells). The calculated survival fraction of $S(90) \\approx 0.4868$ means that nearly half of the cancer stem cells are untouched by the chemotherapy because they remained dormant. These surviving dormant CSCs constitute a reservoir of malignant cells that can reactivate (exit dormancy) at a later time, post-treatment, leading to tumor relapse and progression. This mechanism, where a subpopulation of cancer cells reversibly enters a quiescent state that is insensitive to therapies targeting cell division, is a classic example of non-genetic drug resistance and a major challenge in cancer treatment. The tumor microenvironment, by inducing and maintaining dormancy (as modeled by the low-hazard hypoxic phase), plays a crucial role in promoting this form of chemoresistance.", "answer": "$$\n\\boxed{0.4868}\n$$", "id": "4462558"}]}